Mount Sinai - PRIME — New York, New York

Mount Sinai - PRIME is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Mount Sinai - PRIME has participated in 6 clinical trials.

Therapeutic areas: Metastatic Cancer, Solid Tumor, Hepatitis B.

Sponsors: Symphogen A/S, Inovio Pharmaceuticals, EMD Serono Research & Development Institute, Inc..

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai - PRIME?

Mount Sinai - PRIME has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai - PRIME conducted?

Mount Sinai - PRIME has 6 clinical trials on record. Their work covers Metastatic Cancer, Solid Tumor, Hepatitis B.

Is Mount Sinai - PRIME accredited by Crixeo Health?

Yes — Mount Sinai - PRIME holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Mount Sinai - PRIME?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.